Awareness of Stroke Warning Symptoms -13 States and the District of Columbia, 2005
Although the number of deaths from stroke has declined substantially since the 1960s (1, 2) , in 2004, stroke remained the third leading cause of death in the United States, after heart disease and cancer (3) . Approximately 54% of U.S. stroke deaths in 2004 occurred outside of a hospital (4) . Intravenous administration of tissue plasminogen activator has clinical benefits for patients with acute ischemic stroke; however, treatment should begin within 3 hours of symptom onset for these benefits to be realized (5) . For hemorrhagic stroke, immediate surgery (e.g., aneurysm repair) is crucial to prevent rebleeding that results in serious impairment or death in 40% to 60% of cases (6) . A revised objective of Healthy People 2010 is to increase to 83% the proportion of persons who are aware of the warning symptoms of stroke and the need to telephone 9-1-1 immediately if someone appears to be having a stroke (objective no. 12-8) (7) . To assess public awareness of stroke warning symptoms and the importance of seeking emergency care, CDC analyzed data from an optional module of the 2005 Behavioral Risk Factor Surveillance System (BRFSS) survey that was used in 13 states and the District of Columbia (DC). The results indicated that the percentages of respondents who recognized all five correct symptoms, identified an incorrect symptom, and recognized the need to tele-phone 9-1-1 was low; the percentage who met all three measures was 16.4%. In addition, disparities were observed by race/ethnicity, sex, and education level. Public health agencies, clinicians, and educators should continue to stress the importance of learning to recognize stroke symptoms and the need to telephone 9-1-1 when someone appears to be having a stroke.
BRFSS is a state-based, random-digit-dialed telephone survey of the U.S. civilian, noninstitutionalized population aged >18 years and is conducted in all 50 states, DC, Guam, Puerto Rico, and the U.S. Virgin Islands. However, in 2005, the optional heart attack and stroke module was included in the BRFSS surveys of 13 states* and DC. A total of 71,994 respondents answered questions regarding symptoms of stroke. † An incorrect symptom was included in another question ("Do you think sudden chest pain or discomfort is a symptom of stroke?") to assess the possibility that respondents might answer "yes" to all of the questions in the series without actually considering them. Respondents also were asked to select the one action they would do first, from the following list of actions, if they thought that someone was having a heart attack or stroke: take the person to the hospital, advise the person to call a doctor, call 9-1-1, call a spouse or family member, or do something else. Median response rate for the 13 states and DC, based on Council of American Survey and Research Organizations (CASRO) guidelines, was 54.5% (range: 45.1%-61.3%). Data were weighted to 2005 state population estimates. Age-adjusted prevalence estimates and 95% confidence intervals (CIs) were calculated; statistically significant differences between characteristics were determined by nonoverlapping CIs.
Respondent awareness of stroke warning symptoms was 92.6% for sudden numbness or weakness of the face, arm, or leg, especially on one side; 86.5% for sudden confusion or trouble speaking; 83.4% for sudden trouble walking, dizziness, or loss of balance; 68.8% for sudden trouble seeing in one or both eyes; and 60.4% for a severe headache with no known cause. In addition, 85.9% of respondents said they would call 9-1-1 if they thought someone was having a heart attack or stroke. However, 39.5% of respon- were aware of all five stroke warning symptoms, knew that sudden chest pain is not a stroke warning symptom, and would call 9-1-1 if they thought that someone was having a heart attack or stroke ( Table 2) . Awareness of all five stroke warning symptoms and calling 9-1-1 was higher among whites (41.3%), women (41.5%), and persons at higher education levels (47.6% for persons with a college degree or more) than among blacks and Hispanics (29.5% and 26.8%, respectively), men (34.5%), and persons at lower education levels (22.5% for those who had not received a high school diploma). Among states, the same measure ranged from 27.9% (Oklahoma) to 49.7% (Minnesota). addition, some states with heart disease and stroke prevention programs are conducting activities to increase public awareness of the symptoms of heart attack and stroke and the importance of calling 9-1-1 (8) .
The 2005 results in this report indicate no improvement in awareness of stroke warning symptoms from the 2001 survey (9) , although direct comparisons cannot be made because the areas participating in the optional heart attack and stroke module differed in 2005 (13 states and DC) from 2001 (17 states and the U.S. Virgin Islands). In both surveys, few respondents (17.2% in 2001 and 16.4% in 2005) recognized all five stroke warning symptoms, knew that sudden chest pain is not a stroke symptom, and said they would call 9-1-1 immediately if they thought someone was having a stroke or heart attack. Urgent public health efforts are needed to increase the percentage of respondents who meet these measures and should focus on those symptoms with the least awareness (i.e., severe headache with no known cause and sudden trouble seeing in one or both eyes).
Disparities in awareness of stroke warning symptoms and knowing the importance of telephoning 9-1-1 suggest that public health efforts should be targeted to blacks, Hispanics, men, and persons with less education. A 2006 study determined that Hispanics who only spoke Spanish were less likely than Hispanics who also spoke English to be aware of stroke warning symptoms and what action to take if they thought someone was having a stroke or heart attack (10). In areas in which awareness of stroke warning symptoms is lower, state and local health departments should consider working together to implement general public awareness campaigns.
The findings in this report are subject to at least four limitations. First, BRFSS excludes households without landline telephones, including those households with only cellular telephones. Second, only 13 states and DC participated in the heart attack and stroke module in 2005; therefore, the results might not be generalizable to the entire population of the United States. Third, the finding in this report regarding the percentage of respondents who identified all five stroke warning symptoms (43.6%) differed substantially from the previously reported estimate of 78% from the 2001 National Health Interview Survey (NHIS), which was used as the initial baseline for objective 12-8 in Healthy People 2010 (7) . However, the two results are not directly comparable. NHIS results are representative of the U.S. population, whereas the 2005 BRFSS respondents represented a population with landline telephones in 13 states and DC. Questioning in the two surveys also was structured differently. The NHIS questions did not cover the need to call 9-1-1 and also did not include an incorrect symptom as a check against persons who might answer "yes" to all the stroke symptom awareness questions without actually considering them. Finally, the data collected did not enable determination of whether participants who misidentified the incorrect stroke symptom did not know the correct answer or did not consider the question.
Receiving treatment quickly after a stroke is critical to lowering the risk for disability and even death. Rapid treatment requires that persons 1) recognize the warning symptoms of stroke and 2) call 9-1-1 immediately. These findings indicate a need to increase awareness of stroke warning symptoms in the entire population, and particularly among blacks, Hispanics, men, and persons at lower education levels. In addition, increased education efforts in multiple languages might help improve awareness among nonEnglish-speaking Hispanics and others.
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Arthritis as a Potential Barrier to Physical Activity Among Adults with Diabetes -United States,
and 2007
The American Diabetes Association and the American College of Sports Medicine agree that increasing physical activity among persons with diabetes is an important public health goal to 1) reduce blood glucose and risk factors for complications (e.g., obesity and hypertension) in persons with diabetes and 2) improve cardiovascular disease outcomes (1, 2) . Among adults with diabetes, co-occurring arthritis might present an underrecognized barrier to increasing physical activity, but to date this has not been directly studied. To estimate the prevalence of 1) diagnosed arthritis among adults with diabetes and 2) physical inactivity among adults with diabetes by arthritis status, CDC analyzed combined 2005 and 2007 data from the Behavioral Risk Factor Surveillance System (BRFSS). This report describes the results of that analysis, which indicated that 1) arthritis prevalence was 52.0% among adults with diagnosed diabetes and 2) the prevalence of physical inactivity was higher among adults with diabetes and arthritis (29.8%) compared with adults with diabetes alone (21.0%), an association that was independent of age, sex, or body mass index (BMI). The higher prevalence of physical inactivity among adults who have both diabetes and arthritis suggests that arthritis might be an additional barrier to increasing physical activity. Health-care providers and public health agencies should consider addressing this barrier with arthritis-specific or general evidence-based self-management and exercise programs.
The BRFSS survey is a state-based, random-digit-dialed telephone survey of the civilian, noninstitutionalized U.S. adult population aged >18 years and is conducted in all 50 states, the District of Columbia (DC), Guam, Puerto Rico, and the U.S. Virgin Islands. Diabetes was defined as a "yes" response to the question, "Have you ever been told by a doctor that you have diabetes?" Doctor-diagnosed arthritis was defined as a "yes" response to the question, "Have you ever been told by a doctor or other health professional that you have some form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia?" This question is included in the BRFSS core questionnaire in oddnumbered years only. Physical activity level of respondents was determined from six questions* that asked about frequency and duration of participation in nonoccupational activities (i.e., lifestyle activities) of moderate and vigorous intensity; those reporting no participation in such activities were classified as inactive (i.e., engaged in no nonoccupational physical activity), and all others as active. BMI was calculated from self-reported height and weight.
To obtain adequate sample sizes for greater statistical power, CDC combined data for the 50 states and DC from 2005 and 2007, calculated estimates, and applied an annual average weighting; 95% confidence intervals (CIs) were calculated using sample design factors to account for the multistage probability sample. To assess factors potentially confounding an association between doctor-diagnosed arthritis and physical inactivity among those with diabetes, data were combined across states/areas in unadjusted and adjusted (by age, sex, and BMI) logistic regression models. Age groups were 18-44 years, 45-64 years, and >65 years. BMI groups were underweight/normal weight (BMI <25.0), overweight (BMI 25.0 to <30.0), and obese (BMI >30). Statistical significance was determined by nonoverlapping CIs. State-level estimates then were calculated for the 50 states and DC (reported medians were based on these areas) and for Guam, Puerto Rico, and the U. (Figure) . In logistic regression analyses, the unadjusted odds ratio (OR) for the association between doctor-diagnosed arthritis and physical inactivity among adults with doctor-diagnosed diabetes was 1.6 (CI = 1.3-1.7); adjusted for age and sex, the OR was 1.4 (CI = 1.3-1.5); and adjusted for age, sex, and BMI, the OR was 1.3 (CI = 1.2-1.4). In state-specific analyses, the state median prevalence estimate of physical inactivity among adults with diabetes and arthritis was 28.9% (range: 20.2% in California to 46.4% in Tennessee). The state median prevalence estimate of physical inactivity among adults who had diabetes and no arthritis was 19.5% (range: 9.0% in Alaska to 30.2% in West Virginia) (Table) . (4) . Because physical activity is a recommended selfmanagement strategy for both conditions, examining the effect of co-existing arthritis and diabetes on physical activity levels is warranted.
The results of this analysis indicated that, during 2005 and 2007, doctor-diagnosed arthritis affected approximately half of adults with doctor-diagnosed diabetes. The prevalence of self-reported physical inactivity was significantly higher among those with arthritis and diabetes than among those with diabetes alone. This association remained significant after adjustment for age, sex, and BMI, factors that might have otherwise explained the association. Statespecific estimates were consistent with the overall findings, with state-to-state differences likely attributable to differences in the distribution of factors associated with both arthritis and physical inactivity in the state population. Because BRFSS data are cross-sectional, they can only demonstrate an association; the temporal sequence of condition onset is unknown.
The associations between arthritis and physical inactivity among adults with diabetes found in this analysis suggest that arthritis might be a barrier to being physically active in this population. Being more physically active (e.g., through aerobic exercise or strength training) can benefit persons with either arthritis or diabetes and those with both conditions (1) . Persons with diabetes who are inactive and become more active benefit from improved physical function and glucose tolerance (5), but they face the same common barriers to being more physically active as most adults, such as lack of time, competing responsibilities, lack of motivation, and difficulty finding an enjoyable activity (6) . Those who also have arthritis face additional diseasespecific barriers, such as concerns about aggravating arthritis pain (6) and causing further joint damage, and they might be unsure about which types and amounts of activity are safe for their joints. Health-care providers interested in improving diabetes management might want to especially consider arthritis-related barriers among persons with diabetes who are physically inactive.
Specially tailored self-management education interventions, such as the Chronic Disease Self Management Program (7) and the arthritis-specific Arthritis Foundation Self-Help Program, help adults learn to manage arthritis pain and discuss how to safely increase physical activity (8) are available in many communities and are appropriate for adults with diabetes and arthritis. Self-directed physical activities, including joint-friendly activities such as walking, swimming, and biking, also are appropriate for adults with both conditions. ¶ The findings in this report are subject to at least five limitations. First, doctor-diagnosed arthritis, doctordiagnosed diabetes, and activity level are self-reported in BRFSS and have not been confirmed by a health-care provider or objective monitoring; however, such self-reports have been shown to be valid for surveillance purposes (9, 10) . Second, BRFSS is a telephone survey and does not include persons without landline telephones, persons in the military, or those residing in institutions. Third, comparisons of tabular data between states should be made with caution because the prevalence estimates are not adjusted for population characteristics (e.g., age) that might explain differences. Unadjusted data are presented in this report to provide actual estimates for state-level program planning. Fourth, BRFSS response rates were low for both survey years. BRFSS weighting procedures partially correct for nonresponse. The effect of low response rates is uncertain. Finally, the findings in this report do not account for persons with undiagnosed diabetes.
In 2007, CDC released a reference guide for planning physical activity interventions for older adults, including those with diabetes (2). This guide suggests different programs sensitive to the medical needs of persons with diabetes and those with chronic disease complications or physical limitations, and promotes active aging among persons not yet limited by complications or limitations of diabetes or arthritis. Because arthritis appears to be an additional barrier to increasing physical activity, state-level diabetes programs whose aim is to increase physical activity among adults with diabetes might meet their own goals more readily by integrating their efforts with arthritis programs.
Progress Toward Interruption of Wild Poliovirus TransmissionWorldwide, January 2007-April 2008
In 1988, the World Health Assembly resolved to eradicate poliomyelitis. Subsequently, the Global Polio Eradication Initiative reduced the global incidence of polio associated with wild polioviruses (WPVs) from an estimated 350,000 cases in 1988 to 1,997 reported cases in 2006 and reduced the number of countries that have never succeeded in interrupting WPV transmission from 125 to four (Afghanistan, India, Nigeria, and Pakistan) (1-4). Type 2 WPV (WPV2) circulation was last observed in October 1999 (5) . In February 2007, the World Health Organization (WHO) convened a stakeholders meeting to agree on an accelerated polio-eradication effort to be used during 2007-2008 and establish milestones to monitor progress. Programmatic strategies implemented in 2007 included expanded use of type 1 monovalent oral poliovirus vaccine (OPV) (mOPV1) to eliminate type 1 WPV (WPV1) transmission before type 3 WPV (WPV3)* (6) and targeted use of type 3 monovalent OPV (mOPV3) in selected areas (1) (2) (3) (4) . This report summarizes these strategies and overall progress toward reaching the milestones, including a decline in the overall number of WPV cases to 1,310 in 2007 and substantial progress toward interruption of WPV1 circulation in India in 2008. ¶ Additional information available at http://www.cdc.gov/arthritis/campaigns/ physical_activity/index.htm. * WPV1 is more likely to cause paralytic disease and have a wide geographic spread than WPV3.
Routine OPV Vaccination
Routine vaccination remains an integral component of the polio eradication initiative. Global routine vaccination coverage for infants with 3 doses of trivalent OPV (tOPV) was estimated at 80% in 2006 † (7) , an increase from 73% in 2001. Estimated coverage varied among WHO regions: 65% in the South-East Asian, 75% in the African, 86% in the Eastern Mediterranean, and >93% in the Western Pacific, European, and Americas regions. In the four polioendemic countries, 3-dose tOPV coverage was estimated at 77% in Afghanistan, 58% in India, 61% in Nigeria, and 83% in Pakistan; however, substantially lower coverage (<40%) has been reported in subnational areas with ongoing polio transmission (i.e., northern Nigeria and the northern Indian states of Uttar Pradesh and Bihar) (2,3).
Supplementary Immunization Activities (SIAs) § in 2007
In 2007, 164 SIAs were conducted in 27 countries (60 national immunization days, 86 subnational immunization days, and 18 mop-up rounds with OPV), using a total of 2.32 billion OPV doses delivered to 400 million children aged <5 years. Use of mOPV1 increased from 22% of all administered SIA doses in 2005 to 46% in 2006 and to 52% in 2007, reflecting the programmatic emphasis on interrupting WPV1 transmission (6) . A total of 76 (46%) of the 164 SIAs were conducted in the four polio-endemic countries: 25 in India, 19 in Pakistan, and 16 each in Afghanistan and Nigeria. Of the remaining 88 SIAs, 56 (34% of all SIAs) were conducted in eight countries where WPV was reintroduced through importation, ¶ and 32 (20% of all SIAs) were conducted in 15 countries with no WPVconfirmed cases in 2007 in response to earlier outbreaks or as a precaution against poliovirus importations.
To improve SIA quality, strategies that were introduced in 2006 in the four polio-endemic countries were continued in 2007. Nigeria continued "immunization-plus days" that offered other vaccines (e.g., measles, hepatitis B, and diphtheria and tetanus toxoids and pertussis vaccines) and health interventions (e.g., bednets and deworming medication) in addition to OPV during SIAs (2). Despite repeated SIAs and because of lower routine vaccination coverage in high-risk areas, the proportion of "zero-dose children"** in 2007 was substantially higher in polioaffected (18%) areas in Nigeria than in polio-free areas (2%). In India, the government maintained intensive largescale SIAs in districts of Bihar and western Uttar Pradesh with the highest polio risk, primarily using mOPV1 and concentrating on improving coverage among children aged <2 years. The proportion of zero-dose children in India was <1% in both polio-affected areas and polio-free areas. Afghanistan and Pakistan implemented an approach that included improved cross-border synchronization of polio campaigns. In addition, access during SIAs in insecure areas of Afghanistan that previously were inaccessible by vaccinators improved beginning September 2007, after obtaining the support of antigovernment groups; nonetheless, the proportion of zero-dose children overall for 2007 was 9% in those areas. Otherwise, the proportion of zerodose children was essentially the same in both countries in polio-affected areas (<1%) and polio-free areas (<1%).
Acute Flaccid Paralysis (AFP) Surveillance
The quality of AFP surveillance is monitored by two performance indicators: 1) the rate of AFP cases not caused by WPV (i.e., the nonpolio AFP rate; target for certification: more than one case per 100,000 persons aged <15 years), and 2) the proportion of AFP cases with adequate stool specimens † † (target for certification: >80%). In 2007, each WHO region maintained sensitivity of AFP surveillance to detect paralytic polio cases at certification-standard levels (Table) . Globally, AFP case reporting increased 13%, from 68,519 cases in 2006 to 77,433 cases in 2007, primarily as a result of increased reporting from India. Since 2005, a target reporting rate for all polio-endemic countries and countries at high risk for WPV importation has been more than two nonpolio AFP cases per 100,000 persons aged <15 years (8) . In 2007, all four polio-endemic countries and the eight countries with cases reported in 2007 (because of reintroduced WPV) reached this target rate.
Global Polio Laboratory Network
In 2007, WHO accredited 98% of the 145 global poliovirus network laboratories, which together analyzed approximately 157,000 stool specimens from persons with AFP. In addition, the laboratory network finalized implementa-** Children aged 6-35 months with nonpolio acute flaccid paralysis who had never been vaccinated with OPV, according to vaccination histories provided by their mothers. † † Two specimens collected >24 hours apart, both within 14 days of paralysis onset, and shipped on ice or frozen ice packs to a WHO-accredited laboratory, arriving at the laboratory in good condition. † Most recent year for which data are available; WHO/UNICEF estimates. § Mass campaigns conducted during a brief period (days to weeks) in which 1 dose of OPV is administered to all children aged <5 years, regardless of vaccination history. ¶ Angola, Chad, Democratic Republic of the Congo, Burma (Myanmar), Nepal, Niger, Somalia, and Sudan.
tion of a testing approach in countries of WHO regions with WPV circulation that reduces poliovirus confirmation time by 50% (to 21 days), compared with previous methods. § § The percentage of stool specimens tested from polio-endemic regions in laboratories with capacity for both virus isolation in cell culture and differentiation of wild or vaccine-like viruses increased from 57% in 2006 to 69% in 2007.
WPV Incidence
As Other countries. Ongoing WPV transmission in Angola, Chad, DRC, and Sudan and/or Ethiopia requires continuing efforts to overcome the operational impediments limiting the vaccination of children.
The technical feasibility of polio eradication has been demonstrated repeatedly by the ability to interrupt WPV transmission in some of the most difficult to access and insecure areas in the world, including areas that have limited health infrastructure, such as Somalia. In 2007, the feasibility of polio eradication was highlighted by the substantial progress toward WPV1 interruption in India. The concerted effort to interrupt WPV1 transmission worldwide continues in 2008, with a focus on administering mOPV1 in SIAs, combined with periodic use of mOPV3 and tOPV. Sustained commitment by governments and international partners with ongoing program evaluation and adaptation to changing circumstances is crucial for progress to continue.
Measles -United States, January 1-April 25, 2008
On May 1, this report was posted as an MMWR Early Release on the MMWR website (http://www.cdc.gov/mmwr).
Measles, a highly contagious acute viral disease, can result in serious complications and death. As a result of a successful U.S. vaccination program, measles elimination (i.e., interruption of endemic measles transmission) was declared in the United States in 2000 (1) . 
Measles cases in the United States are reported by state health departments preliminarily to CDC, and confirmed cases are reported officially via the National Notifiable Disease Surveillance System, using standard case definitions † and case classifications. Cases are considered importation associated if they are 1) acquired outside the United States (i.e., international importation) or 2) acquired inside the United States and either epidemiologically linked via a chain of transmission to an importation or accompanied by virologic evidence of importation (i.e., a chain of transmission from which a measles virus is identified that is not endemic in the United States). Other cases in the United States are classified as having an unknown source.
During January 1-April 25, 2008, a total of 64 preliminary confirmed measles cases were reported from the following areas: New York City (22 cases), Arizona (15), California (12), Michigan and Wisconsin (four each), Hawaii (three), and Illinois, New York state, Pennsylvania, and Virginia (one each) (Figure) . Patients ranged in age from 5 months to 71 years; 14 patients were aged <12 months, 18 were aged 1-4 years, 11 were aged 5-19 years, 18 were aged 20-49 years, and three were aged >50 years, including one U.S. resident born before 1957. § Fourteen (22%) patients were hospitalized; no deaths were reported. Transmission occurred in both health-care and community settings. One of the 44 patients for whom transmission setting was known was an unvaccinated healthcare worker who was infected in a hospital. Seventeen (39%) were infected while visiting a health-care facility, including a child aged 12 months who was exposed in a physician's office when receiving a routine dose of measles, mumps, and rubella (MMR) vaccine.
Fifty-four (84%) of the 64 measles cases were importation associated: 10 (16%) of the 64 were importations (five in visitors to the United States and five in U.S. residents traveling abroad) from Switzerland (three), Israel (three), Belgium (two), and India and Italy (one each); 29 (45%) cases were epidemiologically linked to importations; and 15 (23%) cases had virologic evidence of importation. The remaining 10 (16%) cases were from unknown sources; however, all occurred in communities with importationassociated cases. Specimens from 14 patients were genotyped at CDC, and four different genotypes were identified: three from Arizona (genotype D5), three from California (D5), five from New York City (one in a case epidemiologically linked to an imported case from Belgium and four in cases in communities where importations from Israel had occurred; all D4), two from Wisconsin (H1), and one from Michigan (D5).
Fifty-six of the 64 measles cases reported in 2008 have occurred in five outbreaks (defined as three or more cases linked in time or place). In New York City, an outbreak of 22 cases has been reported, including four importations and 18 other cases (10 importation associated). In Arizona, 15 cases have been reported; the index patient was an unvaccinated adult visitor from Switzerland. In San Diego, California, 11 cases have been reported, and an additional case spread to Hawaii; the index patient in the San Diego outbreak was an unvaccinated child who had traveled to Switzerland. In Michigan, four cases have been reported; the index patient was an unvaccinated youth aged 13 years with an unknown source of infection. In Wisconsin, four cases have been reported; the index patient was a person aged 37 years with unknown vaccination status who likely was exposed to a Chinese visitor with measlescompatible illness.
Sixty-three of the 64 patients were unvaccinated or had unknown or undocumented ¶ vaccination status, and one patient had documentation of receiving 2 doses of MMR vaccine. None of the five patients who were visitors to the United States had been vaccinated. Among the 59 patients who were U.S. residents, 13 were aged <12 months and too young to be vaccinated routinely, seven were children aged 12-15 months and had not yet received vaccination, 21 were children aged 16 months-19 years, including 14 (67%) who claimed exemptions because of religious or personal beliefs (Table) . Among the 18 patients aged >20 years, 14 had unknown or undocumented vaccination status, two had claimed exemptions and acquired measles in Europe, one had evidence of immunity because of birth before 1957, and one had documentation of receiving 2 doses of MMR vaccine. Of the five U.S. residents with measles who were vaccine eligible and had traveled abroad, all were unvaccinated. One was a child aged 15 months who was not vaccinated before travel, and two were adults who were unvaccinated because of personal belief exemptions. For two adults, the reason for not being vaccinated was unknown. The limited size of recent measles outbreaks in the United States has resulted from highly effective measles and MMR vaccines, preexisting high vaccination coverage levels in preschool and school-aged children, and a rapid and effective public health response. All children should receive 2 doses of MMR vaccine, with the first dose recommended at age 12-15 months and the second dose at age 4-6 years. Unless they have other documented evidence of measles immunity, § § all adults should receive at least 1 dose. Two doses are recommended for international travelers aged >12 months, health-care personnel, and students at secondary and postsecondary educational facilities. Infants aged 6-11 months should receive 1 dose before travel abroad (3). During a measles outbreak, the vaccination response should be guided by the epidemiology of the outbreak and the outbreak setting and might include offering 1 dose of measles or MMR vaccine to infants aged 6-11 months, offering the second dose to preschool-aged children provided that 28 days have elapsed since the first dose, and recommending 1 dose to health-care workers born before 1957 unless they show other evidence of immunity.
Patients with measles frequently seek medical care, and emergency departments are common sites of measles transmission (4). To prevent transmission of measles in healthcare settings, patients should be asked to wear a surgical mask (if tolerated) for source containment, airborne infection-control precautions (5) should be followed stringently, and patients should be placed in a negative airpressure room as soon as possible. If a negative air-pressure room is not available, the patient should be placed in a room with the door closed. Measles cases should be investigated, patients isolated promptly, and specimens obtained for laboratory confirmation and viral genoptying. Case contacts without documented evidence of measles immunity should be vaccinated, offered immune globulin, or asked to quarantine themselves at home from the fifth day after their first exposure to the twenty-first day after their last exposure. Contacts with measles-compatible symptoms should be managed in a manner that will prevent further spread (3, 5) . * Persons who claimed exemption from vaccination because of religious or personal beliefs. † One infant aged 7 months received a dose of measles, mumps, and rubella (MMR) vaccine (because of an accelerated vaccine schedule) the day before exposure. § One child aged 12 months received a routine MMR vaccine dose on the day of exposure in a physician's office. ¶ One child aged 2 years, who was unvaccinated on the day of exposure, received a dose of MMR vaccine 6 days later; the delay was attributed to a parental request for single-antigen measles vaccine because of vaccine safety concerns. ** Includes two self-reports of receipt of 1 or more doses of measles vaccine. † † Two adults received postexposure MMR vaccine (one on the day of exposure and one on the day after exposure). Health-care personnel place themselves and their patients at risk if they are not protected against measles. In accordance with current recommendations, health-care personnel should have documented evidence of measles immunity ¶ ¶ readily available at their work location (3) . If this documentation is not available when measles is introduced, major costs and disruptions to health-care operations can result from the need to exclude potentially infected staff members and rapidly ensure immunity for others (6) .
Many of the measles cases in children in 2008 have occurred among children whose parents claimed exemption from vaccination because of religious or personal beliefs and in infants too young to be vaccinated. Forty-eight states currently allow religious exemptions to school vaccination requirements, and 21 states allow exemptions based on personal beliefs.*** During 2002 and 2003, nonmedical exemption rates were higher in states that easily granted exemptions than states with medium or difficult exemption processes (7); in such states, the process of claiming a nonmedical exemption might require less effort than fulfilling vaccination requirements (8) .
Although national vaccination levels are high, † † † unvaccinated children tend to be clustered geographically or socially, increasing their risk for outbreaks (6, 9 ). An upward trend in the mean proportion of school children who were not vaccinated because of personal belief exemptions was observed from 1991 to 2004 (7) . Increases in the proportion of persons declining vaccination for themselves or their children might lead to large-scale outbreaks in the United States, such as those that have occurred in other countries (e.g., United Kingdom and Netherlands) (10) .
Ongoing measles virus transmission has been eliminated in the United States, but the risk for imported disease and outbreaks remains. High vaccination coverage in the United States has limited the spread of imported measles in 2008. Nevertheless, the measles outbreaks in 2008 illustrate the risk created by importation of disease into clusters of persons with low vaccination rates, both for the unvaccinated and those who come into contact with them.
Arthritis Awareness Month -May 2008
May is Arthritis Awareness Month, an observance intended to focus attention on the substantial and growing problem of arthritis in the United States. Arthritis, the most common cause of disability in the United States, affects one in five adults and nearly 300,000 children (1) (2) (3) . By the year 2030, approximately 67 million U.S. adults will be affected by arthritis (4), compared with an estimated 46 million during 2003-2005 (3) .
The emphasis of this year's observance is on encouraging persons with arthritis to stay physically active. The U.S. Surgeon General has stated that regular physical activity is necessary for everyone to maintain normal muscle strength, joint structure, and joint function (5) . Moderate physical activity is recommended for all children and adults with arthritis, and walking might be one of the most accessible ways to become physically active. Walking is low impact, can be done almost anywhere and anytime, and requires only a good pair of shoes. For persons with arthritis, walking might be counterintuitive when joints hurt; however, it is a safe, effective, and ¶ ¶ Documented receipt of 2 doses of live measles virus vaccine, laboratory evidence of immunity, documentation of physician-diagnosed measles, or birth before 1957. ** (6) . The program also promotes progress toward achieving the arthritis-related objectives in Healthy People 2010 (7) . Information about physical activity and self-management education programs for adults with arthritis is available from CDC at http://www.cdc.gov/arthritis/ intervention/index.htm. Additional information about Arthritis Awareness Month activities is available from the Arthritis Foundation online (http://www.arthritis.org) or by telephone (800-568-4045).
Notice to Readers

Annual Conference on Assessment Initiative -August 18-20, 2008
The Annual Conference on Assessment Initiative, sponsored by CDC, will be held August 18-20, 2008, in Atlanta, Georgia. This meeting will focus on sharing information on innovative systems and methods that improve the way data are used for public health programs, services, and policies at the local and state levels. Sessions will address data dissemination, health assessment research, applied data analysis, presentation techniques, and community healthassessment processes and outcomes.
Participants will include staff members from local and state health departments, federal agencies, and community organizations interested in the collection, analysis, and dissemination of data for community health assessments. Conference attendees can register online at http://www.ppleventreg.com/ events/hhs/index.php?id=19; the deadline for online registration is August 4, and no registration fee is charged. The deadline for making reservations with the Sheraton Atlanta Hotel is July 14 (at the conference website or by telephone, 800-833-8624 or 404-659-6500).
Abstracts for the poster session are due by July 18 and should be e-mailed to Nelson Adekoya at nba7@cdc.gov. Abstracts should be a maximum of 250 words and clearly state the purpose of the poster. Topics of interest include approaches to assessment, impact and outcome of community health assessment, systems and approaches used for data dissemination, community partnerships, and statistical methods used in assessment. A maximum of 40 abstracts will be accepted, and applicants will be notified of acceptance by August 1. Additional information regarding the Assessment Initiative is available at http://www.cdc. gov/ncphi/od/ai. Table II . § § Updated monthly from reports to the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Implementation of HIV reporting influences the number of cases reported. Updates of pediatric HIV data have been temporarily suspended until upgrading of the national HIV/AIDS surveillance data management system is completed. Data for HIV/AIDS, when available, are displayed in Table IV , which appears quarterly. ¶ ¶ Updated weekly from reports to the Influenza Division, National Center for Immunization and Respiratory Diseases. Sixty-nine cases occurring during the 2007-08 influenza season have been reported. *** No measles cases were reported for the current week.
† † † Data for meningococcal disease (all serogroups) are available in Table II . § § § In 2008, Q fever acute and chronic reporting categories were recognized as a result of revisions to the Q fever case definition. Prior to that time, case counts were not differentiated with respect to acute and chronic Q fever cases. ¶ ¶ ¶ No rubella cases were reported for the current week. **** Updated weekly from reports to the Division of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases. -15  2  174  169  136  70  71  acute  - * Ratio of current 4-week total to mean of 15 4-week totals (from previous, comparable, and subsequent 4-week periods for the past 5 years). The point where the hatched area begins is based on the mean and two standard deviations of these 4-week totals. Table IV , which appears quarterly.
FIGURE I. Selected notifiable disease reports, United States, comparison of provisional 4-week totals May 3, 2008, with historical data
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